For years, the rule was simple and frustrating: Medicare did not cover GLP-1 drugs like Wegovy when they were prescribed purely for weight loss. If you wanted one, you paid the full retail price out of pocket — often more than $1,000 a month. That changes on July 1, 2026.

Through a new demonstration called the Medicare GLP-1 Bridge, eligible Part D beneficiaries will be able to fill certain GLP-1 prescriptions for a flat $50 copay per month — no matter what your specific drug plan covers. This guide lays out exactly who qualifies (the BMI rules are stricter than the headlines suggest), how the $50 price compares to what people pay now, and the step-by-step process to get a prescription filled once the window opens.

What the Medicare GLP-1 Bridge Actually Is

The Medicare GLP-1 Bridge is a temporary federal program run by the Centers for Medicare & Medicaid Services (CMS) as part of a larger test known as the BALANCE Model. The word "bridge" is the key: it's meant to give Medicare beneficiaries access to weight-loss GLP-1 drugs for a limited stretch — from July 1, 2026 to December 31, 2027 — while the long-term coverage rules are still being worked out.

During that window, three medications are covered through the Bridge:

• Wegovy (semaglutide) — all formulations
• Foundayo — all formulations
• Zepbound (tirzepatide) — the KwikPen formulation only

If you're approved, your cost is a flat $50 per month, and that amount doesn't move. It stays $50 whether it's January or December, and whether or not you've met any deductible. Behind the scenes, the drug manufacturers agreed to supply these medications at a reduced net price (about $245 a month) so the program can offer that low copay — but as a beneficiary, the only number you need to remember is $50.

One important framing point: this is a weight-management program. The Bridge covers these drugs when they're prescribed to reduce excess body weight, paired with ongoing lifestyle changes like a structured eating and activity plan. It is not a backdoor for any-and-all uses, and it is not the same as Medicare's existing coverage of these drugs for diabetes or heart conditions, which already follows separate rules.

Do You Qualify? The Exact BMI Rules

This is where most people either get a pleasant surprise or a disappointment, so let's be precise. To be eligible for the Medicare GLP-1 Bridge, you have to clear three bars at the same time:

1. You're enrolled in Medicare Part D. The Bridge only works for people with Part D prescription drug coverage (including the drug coverage built into many Medicare Advantage plans). If you have no Part D, you can't use it.
2. You're 18 or older. Not an issue for the Medicare population, but it's part of the official rule.
3. You meet the BMI threshold — described in the table below.

The BMI rule has two doors, and you only need to walk through one of them:

Medicare GLP-1 Bridge — BMI Eligibility

So if your BMI is 35 or above, you're in on weight alone. If it sits between 27 and 34.9, you can still qualify, but your provider has to document a qualifying weight-related health condition alongside it.

There's a helpful detail for people who are already taking one of these drugs. Eligibility is measured at the point you started GLP-1 therapy. So if you began Wegovy back when your BMI was 37, and the medication has since brought it down to 34, your provider can attest that you met the BMI-35 bar at the start — you don't lose coverage just because the drug worked.

$50 a Month vs. Paying Full Price

The reason this program is getting so much attention comes down to one comparison. Here's roughly what the same month of Wegovy looks like with and without the Bridge:

What You Pay for a Month of Wegovy

The list price of Wegovy runs about $1,349 a month, and people without coverage have typically paid somewhere around $1,000 or more per fill even after manufacturer savings. At $50, the Bridge cuts that to a fraction of what Medicare beneficiaries pay today. Over a full year, that's the difference between roughly $600 and well over $12,000.

How to Get It Starting July 1 — Step by Step

You can't sign up for the Bridge yourself, and there's no special enrollment form for beneficiaries. The process runs through your prescriber. Here's the order of operations once the program opens on July 1, 2026:

1. Confirm you have Part D. Check your Medicare card or your plan's member portal. If you only have Original Medicare (Parts A and B) with no drug plan, the Bridge can't pay — enrolling in Part D would be the first step, during an enrollment period you qualify for.
2. Talk to your doctor or prescriber. Bring up the GLP-1 Bridge specifically. They'll assess whether a GLP-1 is appropriate for you and whether you meet the BMI and condition criteria.
3. Have your provider submit a prior authorization. This is the gatekeeping step. Your provider files a Medicare GLP-1 Bridge prior authorization request — electronically (CMS prefers this) or by fax — attesting that you meet the eligibility rules, along with the prescription.
4. Fill the prescription once approved. After approval, you take the prescription to a participating pharmacy and pay your $50 copay for the monthly supply.

Because the prior authorization is provider-driven, the smartest move you can make before July 1 is simply to book the appointment now. Demand is expected to be heavy in the first weeks, so getting on your doctor's calendar early — and asking them to be ready to file the authorization on day one — is how you avoid a backlog.

What About Your Specific Part D Plan?

Here's the detail that trips people up — and it's actually good news. The Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment system. Part D plan sponsors do not have to opt in for you to use it.

What that means in plain terms: you don't need to shop for a plan that "covers Wegovy," and you don't need to switch plans during open enrollment to access the Bridge. As long as you're enrolled in any Part D drug coverage and you meet the medical criteria, the Bridge is available to you. Your own plan's formulary — its list of covered drugs — doesn't decide this.

This is a meaningful break from how Medicare drug coverage usually works, where the specific plan you chose determines almost everything. With the Bridge, the eligibility lives with you and your prescriber, not with your plan's drug list.

What the Program Won't Do

It's worth being clear-eyed about the limits, because a few of them matter for planning:

• It's temporary. The Bridge is scheduled to end on December 31, 2027. It's designed as a stopgap, so don't assume the $50 price is permanent — coverage rules after that date are still being decided.
• It won't lower the $50 further. Even beneficiaries who normally get extra help (the low-income subsidy) pay the same $50 here. There's no income-based discount layered on top.
• It doesn't help your out-of-pocket cap. Since the copay doesn't count toward TrOOP, it won't speed up reaching your catastrophic phase for your other drugs.
• It's not automatic. No prior authorization on file means no $50 price. The paperwork has to be done first, every time the rules require it.

None of these are reasons to skip the program — for the right person, paying $50 instead of $1,000 is transformative. They're just the fine print worth knowing before you build a budget around it.

Frequently Asked Questions

Bottom Line — What to Do Next

The Medicare GLP-1 Bridge is a genuine shift: for the first time, Medicare beneficiaries with obesity have a clear path to GLP-1 weight-loss drugs at a price that isn't out of reach. If you think you might qualify, here's the order of operations for the weeks around July 1:

1. Confirm your Part D coverage — you need it to use the Bridge at all
2. Check your BMI against the rules (35+, or 27+ with a weight-related condition)
3. Book a provider appointment now so they can file the prior authorization as soon as the program opens
4. Plan around the timeline — remember the program is set to run only through the end of 2027

---

This article is for general informational purposes only and does not replace medical advice from a licensed healthcare provider, nor is it personalized insurance, financial, or tax advice. GLP-1 medications carry risks and side effects and are not appropriate for everyone — always consult your doctor about whether they are right for you. Program details, eligibility rules, covered drugs, and pricing for the Medicare GLP-1 Bridge can change. For your specific situation, contact Medicare directly at 1-800-MEDICARE, review the official details at CMS.gov, or speak with a licensed insurance agent. Information is current as of June 2026.